Neurocrine Biosciences Operating Lease Income - 2022 (Lessor) increased by 14.3% to $4.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.3%, from $3.50M to $4.00M.
operating_lease_income_2022_lessor| Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $1.70M | $1.70M | $2.70M | $3.50M | $3.50M | $3.50M | $3.50M | $4.00M |
| QoQ Change | — | +0.0% | +58.8% | +29.6% | +0.0% | +0.0% | +0.0% | +14.3% |
| YoY Change | — | — | — | +105.9% | +105.9% | +29.6% | +0.0% | +14.3% |